Subjective Improvement in Proprioception in Two Atypical Friedreich's Ataxia Patients Treated with Varenicline (Chantix)

Theresa A. Zesiewicz, Kelly L. Sullivan, Clifton L. Gooch, David R. Lynch

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Two patients with atypical Friedreich ataxia (heterozygotes for a GAA expansion and a G130V point mutation) experienced modest proprioceptive improvements in their extremities within a month of taking varenicline (Chantix), a drug approved for smoking cessation.
Original languageAmerican English
JournalJournal of Clinical Neuromuscular Disease
Volume10
DOIs
StatePublished - Jun 2009

Disciplines

  • Public Health
  • Epidemiology

Keywords

  • Chantix
  • Friedreich ataxia
  • Proprioception
  • Smoking cessation
  • Varenicline

Fingerprint

Dive into the research topics of 'Subjective Improvement in Proprioception in Two Atypical Friedreich's Ataxia Patients Treated with Varenicline (Chantix)'. Together they form a unique fingerprint.

Cite this